Correlation Between Veracyte and Evogene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Evogene, you can compare the effects of market volatilities on Veracyte and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Evogene.

Diversification Opportunities for Veracyte and Evogene

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Veracyte and Evogene is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of Veracyte i.e., Veracyte and Evogene go up and down completely randomly.

Pair Corralation between Veracyte and Evogene

Given the investment horizon of 90 days Veracyte is expected to generate 0.96 times more return on investment than Evogene. However, Veracyte is 1.04 times less risky than Evogene. It trades about -0.11 of its potential returns per unit of risk. Evogene is currently generating about -0.13 per unit of risk. If you would invest  4,000  in Veracyte on December 29, 2024 and sell it today you would lose (988.00) from holding Veracyte or give up 24.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Evogene

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Veracyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Evogene 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Veracyte and Evogene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Evogene

The main advantage of trading using opposite Veracyte and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.
The idea behind Veracyte and Evogene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios